Overview:

The UK digital pathology market is valued for more than US$ XXX.X Mn in 2022 and expected to reach a value of US$ XXX.X Mn by 2032 with a significant CAGR of around XX.X% over the forecast period of 2023-2032. Digital pathology is a technology-driven, image-centric information platform designed to facilitate the organization of data derived from digital slides.

The utilization of digital pathology technology can contribute to a research pipeline in two key ways. Firstly, it allows for the organization of macroscopic images, tissue microarrays, and complete slide images through designated file storage and viewing applications. The second aspect involves leveraging digital pathology for the advancement and incorporation of image analysis techniques in research.

Market Dynamics:

The expansion of the digital pathology market is primarily propelled by the growing incidence of cancer and cardiovascular disorders, an upsurge in the demand for precise diagnostics, and the creation of innovative digital pathology systems by a significant number of major players.

Consequently, with the escalation in the prevalence of chronic and cardiovascular diseases, there is a corresponding increase in the requirement for digital pathology systems, contributing to the advancement of the UK digital pathology market.

Segment Trends:

The UK digital pathology market is segmented on the basis of product type, type, application, and end user.

In terms of application, the disease diagnosis segment played a significant role in 2020 and is anticipated to sustain its dominance throughout the forecast period. This is attributed to the growing prevalence of chronic diseases, an increase in cardiac disorders, and a rising demand for digital pathology systems in disease diagnosis.

Nevertheless, the drug discovery segment is poised for substantial growth in the forecast period, driven by a surge in cancer cases, an uptick in the adoption of digital pathology systems, and the introduction of new digital pathology systems in clinical laboratories.

Scope of the Report:

Detailed Segmentation:

UK Digital Pathology Market, By Product Type:

• Scanners
  • Brightfield Scanners
  • Other Scanners
• Software
• Communication Systems
• Storage Systems

UK Digital Pathology Market, By Type:

• Human Pathology
• Veterinary Pathology

UK Digital Pathology Market, By Application:

• Drug Discovery
• Disease Diagnosis
• Training & Education

UK Digital Pathology Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Hospital & Clinics
• Academic Institutes & Research Laboratories

Key Players Covered:

Key players operating in the market includes, Danaher Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Apollo Enterprise Imaging, Hologic Inc., Sectra AB, Fujifilm Holdings Corporation, Indica Labs Inc., Akoya Biosciences, Inc., and Glencoe Software, Inc.